Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data
- PMID: 32876785
- PMCID: PMC8025280
- DOI: 10.1007/s10067-020-05356-1
Correction to: Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data
Abstract
The original published version of the above article contained an error.
Erratum for
-
Tuberculosis and viral hepatitis in patients treated with certolizumab pegol in Asia-Pacific countries and worldwide: real-world and clinical trial data.Clin Rheumatol. 2021 Mar;40(3):867-875. doi: 10.1007/s10067-020-05248-4. Epub 2020 Aug 1. Clin Rheumatol. 2021. PMID: 32740672 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
